NasdaqCM - Delayed Quote • USD
Dyadic International, Inc. (DYAI)
At close: April 22 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.66 | -0.9 |
| Low Estimate | 0 | 0 | -0.66 | -0.9 |
| High Estimate | 0 | 0 | -0.66 | -0.9 |
| Year Ago EPS | -0.07 | -0.07 | -0.24 | -0.66 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 4.2M | 6.1M |
| Low Estimate | -- | -- | 4.2M | 6.1M |
| High Estimate | -- | -- | 4.2M | 6.1M |
| Year Ago Sales | -- | -- | 2.9M | 4.2M |
| Sales Growth (year/est) | -- | -- | 44.90% | 45.20% |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.08 | -0.05 | -0.06 | -0.06 |
| EPS Actual | -0.07 | -0.07 | -0.06 | -0.08 |
| Difference | 0.01 | -0.02 | 0 | -0.02 |
| Surprise % | 12.50% | -40.00% | 0.00% | -33.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.66 | -0.9 |
| 7 Days Ago | 0 | 0 | -0.66 | -0.9 |
| 30 Days Ago | 0 | 0 | -0.25 | -0.37 |
| 60 Days Ago | 0 | 0 | -0.25 | -0.37 |
| 90 Days Ago | 0 | 0 | -0.25 | -0.37 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | DYAI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 0.20% |
| Next Qtr. | -- | -- | -- | 9.40% |
| Current Year | -175.00% | -- | -- | 4.40% |
| Next Year | -36.40% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.07% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/24/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 2/3/2023 |
| Downgrade | Dawson James: Buy to Neutral | 7/18/2022 |
| Maintains | HC Wainwright & Co.: Buy | 4/5/2022 |
| Initiated | HC Wainwright & Co.: Buy | 12/17/2021 |
Related Tickers
CBO.MU Celsion Corp
1.1500
+5.50%
EVEz.XC
Q91.F Annexin Pharmaceuticals AB (publ)
0.0132
0.00%
8GN.F Cessatech A/S
0.8160
+7.65%
7BG.F BerGenBio ASA
0.0126
+5.00%
RDTCF Rapid Dose Therapeutics Corp.
0.0151
0.00%
KLDO Kaleido Biosciences, Inc.
0.0001
0.00%
ORGS Orgenesis Inc.
0.5072
+1.26%
ALA.AX Arovella Therapeutics Limited
0.1200
+4.35%
ENZN Enzon Pharmaceuticals, Inc.
0.0724
0.00%